APYX Apyx Medical Corporation

NASDAQ
$2.40

Apyx Medical Corporation (APYX) is expected to report earnings on February 4, 2027, before the market open. The consensus earnings estimate is a loss of $0.04 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -7.7% since its last earnings release on November 5, 2026.

Apyx Medical Beat Consensus Estimates, Reaffirms Revenue Guidance
Thursday, November 5, 2026 · 7:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · 7:00 AM ET
Earnings Whisper
-
vs ($0.04)
Rev est $19.38M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.88

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Apyx Medical Corporation

Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium Plasma Technology, Apyx is solely focused on bringing transformative solutions to the physicians and patients it serves.

Sector

Healthcare

Industry

Medical Instruments/Supply

Charts powered in part by Lightweight Charts™ by TradingView.